Sale!

Multiple Myeloma FISH Panel

Original price was: $496.Current price is: $372.

-25%

The Multiple Myeloma FISH Panel is a sophisticated genetic test that utilizes Fluorescence In Situ Hybridization (FISH) technology to detect specific chromosomal abnormalities associated with multiple myeloma. This comprehensive panel analyzes four critical genetic markers: deletion 11q, deletion 13q, IgH rearrangements, and deletion 17p. These genetic alterations play a crucial role in determining disease prognosis, treatment response, and overall survival outcomes. The test is particularly valuable for patients with suspected or confirmed multiple myeloma, providing essential information for personalized treatment strategies. At only $372 USD (discounted from $496), this advanced genetic analysis offers critical insights that can significantly impact treatment decisions and disease management approaches.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Multiple Myeloma FISH Panel: Comprehensive Genetic Analysis for MM Diagnosis

Understanding the Multiple Myeloma FISH Panel

The Multiple Myeloma FISH Panel represents a cutting-edge diagnostic approach in hematologic oncology, specifically designed to detect chromosomal abnormalities that are critical for understanding multiple myeloma progression and treatment response. This sophisticated genetic test employs Fluorescence In Situ Hybridization (FISH) technology, which allows for precise visualization of specific genetic alterations within bone marrow or blood cells.

Multiple myeloma is a complex hematologic malignancy characterized by the uncontrolled proliferation of plasma cells in the bone marrow. The genetic landscape of multiple myeloma plays a pivotal role in determining disease behavior, treatment response, and overall prognosis. The FISH panel provides clinicians with essential genetic information that cannot be obtained through conventional diagnostic methods alone.

What the Test Measures and Detects

The Multiple Myeloma FISH Panel specifically targets four critical genetic markers that have significant clinical implications:

Key Genetic Abnormalities Analyzed

  • Deletion 11q (del11q): This chromosomal deletion affects the 11q region and is associated with specific clinical features and treatment responses in multiple myeloma patients.
  • Deletion 13q (del13q): One of the most common chromosomal abnormalities in multiple myeloma, del13q has important prognostic implications and may influence treatment selection.
  • Immunoglobulin Heavy Chain (IgH) Rearrangements: These genetic alterations involve the immunoglobulin heavy chain locus and are crucial for understanding disease biology and potential targeted therapy options.
  • Deletion 17p (del17p): This high-risk genetic abnormality involves the TP53 tumor suppressor gene and is associated with more aggressive disease and poorer outcomes.

Who Should Consider This Test

The Multiple Myeloma FISH Panel is recommended for individuals presenting with specific clinical scenarios:

Clinical Indications

  • Patients with newly diagnosed multiple myeloma requiring comprehensive genetic profiling
  • Individuals with suspected multiple myeloma based on clinical symptoms and laboratory findings
  • Patients experiencing unexplained bone pain, particularly in the back or ribs
  • Individuals with persistent fatigue, weakness, or recurrent infections
  • Patients showing abnormal protein levels in blood or urine tests
  • Those with renal impairment or anemia of unknown origin
  • Patients requiring risk stratification for treatment planning
  • Individuals being evaluated for stem cell transplantation eligibility

Benefits of Taking the Multiple Myeloma FISH Panel

Undergoing this comprehensive genetic analysis offers numerous advantages for both patients and healthcare providers:

Clinical Advantages

  • Precise Risk Stratification: Identifies high-risk genetic features that may require more aggressive treatment approaches
  • Personalized Treatment Planning: Enables tailored therapy selection based on individual genetic profiles
  • Prognostic Information: Provides valuable insights into disease progression and expected outcomes
  • Early Detection of High-Risk Features: Identifies genetic abnormalities that may impact treatment response
  • Monitoring Disease Evolution: Helps track genetic changes over time and during treatment
  • Informed Clinical Decision-Making: Supports evidence-based treatment choices and management strategies

Understanding Your Test Results

Interpreting the Multiple Myeloma FISH Panel results requires careful consideration by qualified hematologists and oncologists:

Result Interpretation Guidance

  • Normal Results: Absence of the tested genetic abnormalities suggests standard-risk disease characteristics
  • Presence of del13q: May indicate intermediate-risk disease requiring standard treatment protocols
  • Detection of del17p: Suggests high-risk disease that may benefit from more intensive therapy approaches
  • IgH Rearrangements: Can influence treatment selection, particularly regarding targeted therapies
  • Multiple Abnormalities: The presence of multiple genetic alterations may indicate more complex disease biology

It’s important to note that test results should always be interpreted in the context of your complete clinical picture, including symptoms, laboratory findings, and other diagnostic tests. Your healthcare provider will explain what your specific results mean for your treatment plan and overall prognosis.

Test Details and Pricing

Test Component Details
Test Name Multiple Myeloma FISH Panel
Discount Price $372 USD
Regular Price $496 USD
Turnaround Time 5-7 days
Sample Type Bone marrow / Peripheral blood (Transport immediately)
Test Components Sodium Heparin Vacutainer (2ml)
Pre-test Instructions Requires Doctor’s prescription (not applicable for surgery, pregnancy, or travel abroad cases)

Nationwide Testing Availability

GGC DNA provides comprehensive Multiple Myeloma FISH Panel testing services across the United States. We have established branches in all major metropolitan areas, ensuring convenient access to this advanced genetic testing regardless of your location. Our network includes facilities in:

  • New York City and surrounding areas
  • Los Angeles and Southern California
  • Chicago and the Midwest region
  • Houston and Texas metropolitan areas
  • Miami and Florida locations
  • Seattle and Pacific Northwest centers
  • And many other major cities nationwide

Take Control of Your Health Journey

The Multiple Myeloma FISH Panel provides critical genetic information that can significantly impact your treatment journey and overall outcomes. By understanding the specific genetic characteristics of your disease, you and your healthcare team can make more informed decisions about your care.

Don’t leave your genetic profile to chance. Our experienced genetic counselors and oncology specialists are available to discuss your testing options and help you understand how this advanced analysis can benefit your specific situation.

Ready to Schedule Your Test?

Take the next step in your healthcare journey by scheduling your Multiple Myeloma FISH Panel today. Our dedicated team is ready to assist you with the testing process and ensure you receive the comprehensive genetic insights you need.

Call or WhatsApp us now at +1(267) 388-9828 to book your appointment or to speak with one of our genetic specialists.

Early and accurate genetic profiling can make a significant difference in your treatment approach and long-term outcomes. Contact us today to learn more about how the Multiple Myeloma FISH Panel can provide the critical information needed for personalized cancer care.